Royal Marsden NHS Foundation Trust, Sutton, United Kingdom. Correspondence to: Dr Nirmalya Roy Moulik, Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.
Lady Hardinge Medical College, New Delhi, India.
Indian Pediatr. 2019 Dec 15;56(12):1041-1048.
Children with cancer need to be immunized against the common vaccine-preventable diseases after completion and sometimes during ongoing treatment of cancer. However, the immunization schedule for these children needs to be altered due to disease and treatment related immune-suppression. Consequently, there are many guidelines/practice statements from around the world to address this issue, however, there is no such comprehensive guideline from India catering to the need of Indian children with cancer.
A guideline was drafted after reviewing the available literature. The draft guideline was discussed and modified in a meeting attended by pediatric oncologists from the PHO chapter and vaccine experts from the ACVIP of the IAP. Subsequently, the modified draft was reviewed and recommendations were finalized.
To review the current evidence and generate a nationally relevant guideline for immunization of children receiving chemotherapy for cancer.
Live vaccines are contraindicated during and up to 6 months after end of chemotherapy. Non-live vaccines are also best given after 6 months from the end of treatment for durable immunity. Annual inactivated influenza vaccine is the only vaccine recommended for all children during chemotherapy whereas hepatitis B vaccine is recommended only for previously unimmunised children with risk of transfusion associated transmission of infection. Post-treatment re-immunization/catch-up schedule largely depends on the pre-chemotherapy immunization status. Sibling immunization should continue uninterrupted except for oral polio vaccine which needs to be substituted by the injectable vaccine. Inactivated influenza vaccine is recommended and varicella vaccine is encouraged for all contacts including siblings.
癌症患儿在完成癌症治疗后,有时在癌症治疗过程中,需要针对常见的可通过疫苗预防的疾病进行免疫接种。然而,由于疾病和治疗相关的免疫抑制,这些儿童的免疫接种计划需要进行调整。因此,世界各地有许多针对这一问题的指南/实践声明,但印度没有这样一份针对印度癌症儿童需求的全面指南。
在审查现有文献后起草了一份指南。在 PHO 分会的儿科肿瘤学家和 IAP 的 ACVIP 的疫苗专家参加的会议上讨论并修改了指南草案。随后,对修改后的草案进行了审查,确定了建议。
回顾现有证据,并为接受癌症化疗的儿童制定一份与国家相关的免疫接种指南。
活疫苗在化疗期间和化疗结束后 6 个月内禁用。非活疫苗也最好在治疗结束后 6 个月后给予,以获得持久免疫力。在化疗期间,所有儿童都建议接种年度灭活流感疫苗,而乙型肝炎疫苗仅建议给以前未免疫且有输血相关感染风险的儿童接种。治疗后重新免疫/补种计划在很大程度上取决于化疗前的免疫接种状况。除了需要用注射用疫苗替代的口服脊髓灰质炎疫苗外,应不间断地为兄弟姐妹进行免疫接种。建议所有接触者(包括兄弟姐妹)接种灭活流感疫苗和水痘疫苗。